Auteur K. SAFREED-HARMON

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Hepatitis C services at harm reduction centres in the European Union: a 28-country survey

J. M. PERICAS ; D. J. BROMBERG ; D. OCAMPO ; E. SCHATZ ; I. WAWER ; P. WYSOCKI ; K. SAFREED-HARMON ; J. V. LAZARUS | 2019
Dans Harm Reduction Journal (Vol.16, 2019) Article : Périodique

Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses [Viewpoint]

J. V. LAZARUS ; K. SAFREED-HARMON ; S. R. STUMO ; M. JAUFFRET-ROUSTIDE ; M. MATICIC ; T. REIC ; E. SCHATZ ; J. TALLADA ; M. HARRIS ; HEP-CORE STUDY GROUP | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

In 2016, the World Health Organization (WHO) called for the elimination of viral hepatitis as a public health threat and established the ambitious targets of achieving an 80% reduction in new infections and a 65% reduction in deaths from hepatit[...]

Plus d'info

Ajouter à la sélection